Welgus Howard G. bought ARQT
August 17, 2026 · Form 4 insider transaction
Welgus Howard G. bought 822 shares of Arcutis Biotherapeutics, Inc. at $6.52 per share, a transaction worth $5.4K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
822
Price
$6.52
Total value
$5.4K
InsiderWelgus Howard G.
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 17, 2026
Filing dateAugust 19, 2026
Shares owned after37,931
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on March 13, 2026, by the Reporting Person, with a plan end date of June 15, 2027.